Glaukos (GKOS) News Today

Summary for Glaukos Corporation (NYSE:GKOS):

• Positive Sentiment: Q2 revenue grew 30% year-over-year, topping analyst estimates by 7.4%. Glaukos (GKOS) Q2 Revenue Jumps 30%
• Positive Sentiment: UBS raised its price target on GKOS to $134.00 and maintained a “buy” rating, implying over 50% upside. UBS Group Raises Glaukos (NYSE:GKOS) Price Target to $134.00
• Positive Sentiment: Wells Fargo lifted its GKOS target to $92.00 with an “equal weight” rating, signaling a moderate upside. Wells Fargo & Company Raises Glaukos (NYSE:GKOS) Price Target to $92.00
• Neutral Sentiment: The full Q2 2025 earnings call transcript was released, offering detailed commentary on performance and outlook. Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript
• Neutral Sentiment: The accompanying Q2 slide presentation is available, detailing segment results and R&D investments. Glaukos Corporation 2025 Q2 - Results - Earnings Call Presentation
• Neutral Sentiment: A Yahoo Finance preview outlined key metrics to watch ahead of the Q2 report, including margin trends and product launches. Glaukos Corp (GKOS) Q2 2025 Earnings Report Preview: What To Look For
• Negative Sentiment: Shares slid nearly 10% after Q2 results as investors reacted to cautious guidance and ongoing operating losses. Glaukos (NYSE:GKOS) Trading Down 9.9% - Time to Sell?
• Negative Sentiment: Concerns over guidance led shares lower, with analysts flagging that revenue beats were overshadowed by persistent losses. Glaukos shares fall as revenue beat overshadowed by guidance concerns